vistagen.com (VTGN): Qarzning balans kapitallashuviga nisbati
Vistagen Therapeutics (VTGN) klinika ittifoqlari orqali xavotirni davolash sinovlarini tezlashtirmoqda, shu bilan birga GURU.Markets dagi qarzning kapitalga nisbati grafigi 0.03 miqdorida qotganini ko'rsatmoqda. Kompaniya nojo'ya ta'sirlarni yo'q qilish uchun qon oqimini chetlab o'tuvchi burun spreylarini joriy qilmoqda. Keyingi o'sish 3-bosqich sinovlari natijalari va naqd pul rezervlarining qat'iy nazoratiga asoslangan.
&width=1200&height=400&colorIndex=0&v=mvujvhid.si-7ayy9s0&start=20220704&end=20261030&filename=GURU_Markets_-_VTGN_-_Vistagen-Therapeutics_-_Debt-to-Net-Assets-Ratio "VTGN: Vistagen Therapeutics Qarzning balans kapitallashuviga nisbati 04.07.2022 - 30.10.2026 | 👁️GURU.Markets👁️")
Vistagen Therapeutics kompaniyasining tahliliy kesimlari
- aksiya narxi va konsensus maqsadli narx:
- birja kapitallashuvi ma'lumotlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning kapitalga nisbati Vistagen Therapeutics|VTGN - Uzoq muddatli qarzdorlikning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Vistagen|VTGN - Kompaniyaning umumiy qarz majburiyatlari|Qarzning balans qiymatiga nisbati VTGN|VTGN - Uzoq muddatli majburiyatlar miqdori|Kompaniyaning qisqa muddatli qarzlari Vistagen|Tezkor likvidlik koeffitsiyenti vistagen.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
Kompaniyaning har tomonlama tahlili:VistaGen Therapeutics Inc (VTGN)
Investorlar aktivlarning operatsion kuchini qarzning kapitalga nisbati orqali baholaydilar. Himoyaviy neyropsixiatriya sektoridagi Vistagen Therapeutics (VTGN) uchun moliyaviy barqarorlik bozor sikllaridan ko'ra klinik muvaffaqiyatga bog'liqdir. Qarzning kapitalizatsiyaga nisbati moliyaviy tuzilmadagi leveraj ulushini aks ettiradi. Past leveraj uzoq davom etadigan dori sinovlari paytida bankrotlik xatarlarini minimallashtirib, kompaniyaning biznes modelining yuqori chidamliligini tasdiqlaydi.
Raqobatdosh kompaniyalar
Biogen Inc. - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar neurocrine.com NBIX|RGC - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati AXSM (Axsome)|ACADIA Pharmaceuticals Inc (ACAD) - Qarzning balans kapitallashuviga nisbati|Balans qiymatiga qarzlar Xenon Corp (XENE)|Qarzning balans qiymatiga nisbati VKTX|Qarzning balans kapitallashuviga nisbati SUPN|Balans kapitallashuviga qarzlar CPRX|Sof aktivlarga qarzlar Denali|Qarzning balans kapitallashuviga nisbati Harmony Pharma HRMY|Sof aktivlarga qarzlar Biohaven Corp (BHVN)|AMLX: Qarzning balans qiymatiga nisbati|trevitherapeutics.com - Qarzning balans kapitaliga nisbati|PRAX: Balans kapitallashuviga qarzlar|Anavex (AVXL) - Balans kapitallashuviga qarzlar|CBLL (CeriBell Corp) - Balans kapitallashuviga qarzlar|PRTA - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar ALEC|ANNX - Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati Omeros OMER|NGNE: Qarzning balans qiymatiga nisbati|ACIU: Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati VYGR (Voyager Corp)|NMRA (Neumora Therapeutics) - Qarzning balans qiymatiga nisbati|SCLX: Qarzning balans kapitaliga nisbati|TVGN (Tevogen Bio) - Balans kapitallashuviga qarzlar|ACOG: Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar CGTX|IKT - Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati Cassava Sciences, Inc. SAVA|Qarzning sof aktivlarga nisbati ASRT|Coya - Balans kapitallashuviga qarzlar|OVID - Balans kapitallashuviga qarzlar|Acumen Pharma (ABOS) - Qarzning balans kapitallashuviga nisbati|Qarzlarning balans kapitallashuviga nisbati CRVO (CervoMed Corporation)|ATHE (Alterity Therapeutics Ltd.) - Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar Clene Nanomedicine CLNN|Qarzning balans qiymatiga nisbati PEPG (PepGen Inc.)|Balans kapitallashuviga qarzlar Jupiter Neurosciences, Inc. (JUNS)|Relmada - Qarzning balans qiymatiga nisbati|Qarzning balans kapitaliga nisbati ANVS (Annovis Bio Corporation)|Grace Tx - Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar fireflyneuro.com AIFF|KLTO: Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati NeuroSense Therapeutics Ltd.|Qarzning balans kapitallashuviga nisbati Reviva Pharmaceuticals Holdings|MetaVia, Inc. (MTVA) - Sof aktivlarga qarzlar|Qarzning balans qiymatiga nisbati NRXS (NeurAxis, Inc.)|Qarzning balans kapitallashuviga nisbati HSDT (heliusmedical.com)|Passage Bio - Qarzning balans qiymatiga nisbati|Qarzning balans kapitaliga nisbati NEUP (Neuphoria Therapeutics, Inc.)|Minerva Neurosciences Corp - Balans kapitallashuviga qarzlar|Qarzning sof aktivlarga nisbati Athira Pharma Corp (ATHA)|Addex Therapeutics (ADXN) - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati ALZN|Qarzning balans kapitallashuviga nisbati Cyclerion Therapeutics Inc.|Qarzning balans qiymatiga nisbati PTIX (Protagenic)|Balans kapitallashuviga qarzlar KTTA|CRGT - Balans qiymatiga qarzlar|Avenue Therapeutics - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar brainstorm-cell.com BCLI|CARA - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati CHRO (Chromocell Therapeutics Corp)|eliemtx.com (ELYM) - Qarzning balans kapitallashuviga nisbati|Balans qiymatiga qarzlar Intra-Cellular Therapies, Inc. (ITCI)|Qarzning balans qiymatiga nisbati LBPH|Qarzning balans kapitallashuviga nisbati MRNS|Balans kapitallashuviga qarzlar NKGN|Sof aktivlarga qarzlar NeuroBo Pharmaceuticals Inc|Qarzning balans kapitallashuviga nisbati Sage Therapeutics, Inc SAGE|Sof aktivlarga qarzlar Synaptogenix, Inc (SNPX)|TRVN: Qarzning balans qiymatiga nisbati|Vigil Neuroscience - Qarzning balans kapitaliga nisbati|WENA: Balans kapitallashuviga qarzlar|Cerevel Therapeutics Inc (CERE) - Balans kapitallashuviga qarzlar